Acceptability of a Fixed Combination of Fenofibrate and Metformin
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective was to assess the acceptability of a 4-week treatment of 4 new
fixed-dose combinations of fenofibrate and metformin, in patients with type 2 diabetes and
dyslipidemia.